← Eichor
Study identifier: NCT06562231 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Development of Isthmocele Symptom Severity and Quality of Life Scale

Condition: Quality of Life  ·  Sponsor: Hilal Yuvacı

PhaseN/A
Planned participants330
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersNo

About this study

Isthmocele, also known as cesarean scar defect (CSD), is the disruption of the integrity of the myometrium in the cesarean section incision and the indentation of the opening in the myometrium towards the visceral peritoneum. Residual menstrual blood accumulating in the isthmocele sac can cause chronic endometritis, anormal uterine bleeding, infertility and chronic pelvic pain. There is currently no quality of life scale that assesses isthmocele symptoms. A scale is needed to determine the positive effect on the patient's quality of life after the surgeries are performed. This study it is aimed to develop a scale that evaluates the severity of isthmocele symptoms and the impact on quality of life due to isthmocele.

This description comes directly from the study's public registry record.

Talk to the study team

Hilal Uslu Yuvacı  ·  +905056236937  ·  hilaly@sakarya.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Sakarya University School of MedicineSakarya, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06562231